rCSP/AP10-602 [GLA-LSQ] Vaccine Trial
- Conditions
- Plasmodium Falciparum Infection
- Interventions
- Other: AP10-602Other: Malaria challengeBiological: rCSP
- First Posted Date
- 2018-07-18
- Last Posted Date
- 2023-07-10
- Target Recruit Count
- 65
- Registration Number
- NCT03589794
- Locations
- 🇺🇸
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States
Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants
- Conditions
- Diphtheria ImmunisationClostridium Difficile ImmunisationDiphtheriaTetanusTetanus ImmunisationPertussis
- Interventions
- Biological: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed onto aluminum hydroxideBiological: Tetanus and Diphtheria Toxoids Adsorbed
- First Posted Date
- 2018-07-18
- Last Posted Date
- 2023-01-20
- Target Recruit Count
- 399
- Registration Number
- NCT03589768
- Locations
- 🇲🇱
Center for Vaccine Development - Mali, Bamako, Mali
A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)
- Conditions
- ImmunisationEbola Disease
- Interventions
- Biological: ChAd3-EBO-ZOther: PlaceboBiological: MVA Multi-Filo Ebola Vaccine
- First Posted Date
- 2018-07-11
- Last Posted Date
- 2024-03-25
- Target Recruit Count
- 61
- Registration Number
- NCT03583606
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center Vaccine Research Center, Cincinnati, Ohio, United States
A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine
- Conditions
- Influenza
- Interventions
- Biological: H7N3 pLAIVBiological: H7N9 pIIV
- First Posted Date
- 2018-07-10
- Last Posted Date
- 2019-03-25
- Target Recruit Count
- 20
- Registration Number
- NCT03581903
- Locations
- 🇺🇸
University of Rochester Medical Center Vaccine Research Unit (Outpatient), Rochester, New York, United States
Liver Transplantation With Tregs at MGH
- Conditions
- Liver Transplant
- Interventions
- First Posted Date
- 2018-07-05
- Last Posted Date
- 2023-12-08
- Target Recruit Count
- 9
- Registration Number
- NCT03577431
- Locations
- 🇺🇸
Massachusetts General Hospital: Transplantation, Boston, Massachusetts, United States
Combination Therapy With 3BNC117 and 10-1074 in HIV-Infected Individuals
- Conditions
- HIV
- Interventions
- Biological: PlaceboBiological: 3BNC117 and 10-1074
- First Posted Date
- 2018-06-27
- Last Posted Date
- 2022-02-09
- Target Recruit Count
- 27
- Registration Number
- NCT03571204
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients
- Conditions
- Tuberculosis, MDR
- Interventions
- First Posted Date
- 2018-06-26
- Last Posted Date
- 2024-06-11
- Target Recruit Count
- 5610
- Registration Number
- NCT03568383
- Locations
- 🇵🇭
De La Salle Health Science Institute Angelo King Medical Research Center (DLSHSI-AKMRC), Cavite, Philippines
🇹🇭Chiangrai Prachanukroh Hospital NICHD CRS, Chiang Mai, Thailand
🇰🇪Kenya Medical Research Institute/Walter Reed Project Clinical Research Center (KEMRI/WRP) CRS, Kericho, Rift Valley, Kenya
Vaginal Microbiome Exposure and Immune Responses in C-section Infants
- Conditions
- Allergic DiseasesAsthma
- Interventions
- Biological: C-section -Vaginal seedingDrug: C-section - Placebo SeedingOther: standard care
- First Posted Date
- 2018-06-26
- Last Posted Date
- 2024-10-18
- Target Recruit Count
- 114
- Registration Number
- NCT03567707
- Locations
- 🇺🇸
Mount Sinai West, New York, New York, United States
🇺🇸Icahn School of Medicine at Mount Sinai, New York, New York, United States
Phase I Study to Evaluate a Human Monoclonal Antibody (MAb) 10E8VLS Administered Alone or Concurrently With MAb VRC07-523LS Via Subcutaneous Injection in Healthy Adults
- Conditions
- Healthy Adult Immune Response
- Interventions
- Biological: VRC-HIVMAB095-00-AB (10E8VLS)Biological: VRC-HIVMAB075-00-AB (VRC07-523LS)
- First Posted Date
- 2018-06-21
- Last Posted Date
- 2020-12-30
- Target Recruit Count
- 9
- Registration Number
- NCT03565315
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine Study
- Conditions
- HIV Infections
- Interventions
- Biological: Full-length p55^gag pDNA vaccineBiological: PlaceboBiological: p24CE1/2 pDNA vaccineBiological: p24CE1/2 pDNA vaccine admixed with full-length p55^gag pDNA vaccine
- First Posted Date
- 2018-06-18
- Last Posted Date
- 2022-04-26
- Target Recruit Count
- 45
- Registration Number
- NCT03560258
- Locations
- 🇺🇸
Northwestern University CRS, Chicago, Illinois, United States
🇺🇸Ohio State University CRS, Columbus, Ohio, United States
🇺🇸UCLA CARE Center CRS, Los Angeles, California, United States